In individuals with type 2 diabetes, augmented hypoglycemic responses of various inflammatory markers, including VEGF, and an attenuated rise of IL-6 during hyperinsulinemia have been reported [30–32]. The gene discussed is VEGFA; the disease is Hyperinsulinemia.